Introduction
The proteoglycan family (PGs) is one of the most abundant natural types of glycoproteins that occur in all tissues, on cell surfaces, and in the extracellular matrix (ECM) [1] . Glycosaminoglycans (GAGs) represent the saccharide moieties of PGs that perform a myriad of physiological functions. GAG polymers are extensively sulfated, repeating disaccharide units of pyranosyl uronic acid, and either 2-amino-2-deoxy D-glucopyranose (glucosamine) or 2-amino-2-deoxy D-galactopyranose [2] . Heparin (HP) and heparan sulfate (HS) are members of the GAG family that are involved in many important biological functions such as blood coagulation, cell growth differentiation, and angiogenesis [3] . HP and HS are linear sulfated polysaccharides having a basic disaccharide unit composed of a uronic acid (1→4) linked to a 2-amino-2-deoxy-D-glucopyranose. The uronic acid may be either D-glucuronic or L-iduronic acid, while O-sulfation may occur on position 2 of the uronic acid and on positions 3 and/or 6 of the amino sugar. The glucosamine nitrogen may be sulfated, acetylated or, less frequently, unmodified, thus resulting in 48 possible disaccharides [4] . The diversity grows exponentially with the polymer length, giving 2304 possible tetrasaccharides, 110,592 hexasaccharides, and more than 5 × 10 6 octasaccharides. All of the theoretical structures resulting from HP and HS biosynthesis cannot be expressed; however, 23 compounds are characterized in the literature [2a] . The polymer, typically composed of 50-200 disaccharide units (25-100 kD), is not fully heterogeneous. Fairly regular N-acetylated regions, mainly composed of glucuronic acid and N-acetylated glucosamine, separate heavily variable N-sulfated regions. The latter are typically three to eight disaccharides long, while the former are more regular approximately 15 disaccharides in length [5] . The N-sulfated regions are expressed dynamically and specifically at the cell surface and are responsible for specific interactions with various proteins [6] . The isolation of N-acetylated and N-sulfated fragments by enzymatic or chemical degradation of the polymer is impeded by a low level of occurrence. Moreover, HP and HS fragments purified by size exclusion and ion-exchange chromatography after de-polymerization are often found to be non-homogeneous [7] . The primary interaction between HP or HS and a protein is an attraction between the highly negatively charged N-sulfated regions and clusters of basic residues at the protein surface, mainly arginines and lysines. In some cases, for example, with antithrombin III (AT-III) [8] , fibroblast growth factors (FGFs) [6] , or stromal cell-derived factor (SDF-1) [9] , the cellular receptors are activated by ligand-induced dimerisation requiring HP or HS proteoglycans (HSPGs). The general consensus is that highly sulfated oligosaccharides containing at least six saccharide units comprised of iduronic acid are required to promote signaling. Interestingly, a paper by van Boeckel et al [10] demonstrated that a pentasaccharide in the HP chain with a precise uronic acid content and sulfation patterns was bound with high affinity and specificity to AT III and was responsible for the anti Xa properties of HP. However, for proteins other than antithrombin, such as platelet factor 4 (PF-4), regulated-on-activation normally Tcell expressed and secreted proteins (RANTES) (9-68) [11] , or macrophage inflammatory protein (MIP) 1α [12] , the epimerization and sulfation patterns responsible for selective binding of a given protein are generally unknown.
The oligosaccharide sequence and sulfation pattern of the HP or HS fragment required for activation or deactivation of a given protein is often difficult to determine [13] . For this reason, it is desirable to develop effective syntheses of heparin-like oligosaccharide chains with defined size, sequence, and charge distribution to be used in interaction studies. Impressive advances in the synthesis of HS fragments were made in the last decade. HS fragments having diverse structures were synthesized [14] [15] [16] . In this paper, a brief method is reported for the preparation of a set of disaccharide building blocks that form the basis of a combinatorial approach for synthesis of several HS fragments. In order to avoid tedious deprotection schemes, a protective group pattern was selected that distinguished clearly between positions to be sulfated and positions remaining as free hydroxyl groups. Acetyl and/or levulinoyl esters protected the positions to be sulfated, while benzyl ethers were used for permanent protection. A p-methoxybenzyl group (PMB) at the 4-position avoided the need to prepare a special building block for masking the nonreducing end of the molecule. The PMB group should be removed either together with the benzyl ethers, by hydrogenolysis at the last step of the synthesis, or selectively, by oxidation or acidic treatment. The anomeric positions were protected by an allyl group that was removed to give a disaccharide donor after activation of the anomeric position. The orthogonality of the PMB and allyl groups were used for further elongation of the chain by recurrent deprotection and activation steps [15c] . The hydroxyl group, OH-6, of glucosamine moieties were protected as TBDPS ethers to avoid oxidation and selectively removed by treatment with HF in pyridine. The disaccharide building blocks were central to the strategy for preparation of longer GlcUA-containing GAG fragments. A 2+2 strategy is under investigation for the preparation of tetrasaccharides and will be discussed elsewhere. The tetrasaccharides thus formed will utilize the same protecting group pattern at the anomeric and 4'-positions, allowing further iterative chain elongation using sequential addition of disaccharides to be performed.
Results and discussion
Two attractive routes for preparing thioglycosyl donors 11 and 12 from the commercial glucal 1 were established (Scheme 1). The known 4,6-di-O-(tert-butyl)silanediyl-D-glucal (2) [17] was obtained in 75 % yield by reaction of 1 with di-tert-butyl-silylditriflate (tBu 2 Si(OTf) 2 ) in DMF. Benzylation of the free hydroxyl group of 2 produced 3 (84 %). Reaction of glucal 3 with tetrabutylammonium fluoride (TBAF) in THF yielded diol 4 (78 %). Regioselective benzylation of the OH-6 position of glucal 4 produced 5 (76 %) by reaction with dibutyltin dimethoxide (Bu 2 Sn(OCH 3 ) 2 ) to produce the corresponding 4,6-tin acetal followed by reaction with BnBr and tetrabutylammonium iodide (Bu4NI) [18] . Reaction of 5 with PMB chloride, sodium hydride and a catalytic amount of Bu 4 NI in DMF gave glucal 6 (73 %). The key intermediate 6 was prepared by a alternative route from glucal 1. Thus, reaction of 1 with tert-butyldimethylsilyl chloride (TBDMSCl) (2 equiv) and imidazole in DMF yielded the known glucal 7 [19] as a waxy white solid (90 %). The OH-4 functional group of 7 was protected as the PMB ether using standard methods to generate 8 (89 %) as a clear oil. Desilylation of 8 with TBAF in THF at 0
• C produced 9 (93 %); thereby, protection of the OH-3 and OH-6 groups of glucal 9 was achieved by treatment with benzyl bromide (3 equiv) and sodium hydride in DMF to generate the key glucal 6 (78 %) as a waxy white solid. Reaction of 6 with dimethyldioxirane (DMDO) in CH 2 Cl 2 [20] , generated in situ the expected epoxide derivative, Addition of ethanethiol and a catalytic amount of trifluoroacetic anhydride generated the β-thioethylglucoside 10 (71 %). Analysis of the 1 H-NMR (chloroform-d) spectrum of the crude intermediate 10 indicated a (10:1β:α) stereoselectivity. The isomers were separated chromatographically. The β-anomer of 3,4,6-tri-O-benzyl glucal was reportedly the sole stereoisomer isolated [21] . The observed stereoselectivity of thioglycosylation of the epoxy-6 generated in situ may be attributed to the nature of the protecting groups. The donor 10 was an attractive agent in terms of the overall design of the synthesis. The OH-2 functional group of compound 10 was thus protected by an acetate, by allowing 10 to react with Ac 2 O-Py-4,4'-dimethylamino pyridine (DMAP) yielding compound 11 (77 %), or as a levulinoyl ester, by allowing 10 to react with a mixture of levulinic acid, 1,3-dicyclohexylcarbodiimide (DCC), and DMAP in CH 2 Cl 2 to produce compound 12 (85 %). Two differentially protected glycosyl acceptors (Scheme 2), based on a modified procedure developed by the Boons group [22] , were synthesized. The known β-allyl glycoside 14 was isolated in 91 % yield from the readily available N-acetylglucosamine pentaacetate (13) by reaction with allyl alcohol and TMSOTf. De-O-acetylation of 14 by treatment with NaOMe in MeOH produced 15 (88 %) that was not isolated but was directly converted into the 4,6-di-O-benzylidene derivative 16 (77 %) by reaction with benzaldehyde dimethylacetal and a catalytic amount of camphorsulfonic acid (CSA) in CH 3 CN. The N-acetyl functionality of compound 16 was removed by heating with aqueous Ba(OH) 2 [23] to yield the amino sugar 17 after neutralization with aqueous sulfuric acid (1N). Treatment of 17 with triflic azide and CuSO 4 in MeOH [24] produced the azido sugar 18 in 74 % yield. The OH-3 functional group of compound 18 was protected as the benzyl ether, by reaction with benzyl bromide and sodium hydride in DMF yielding compound 19 (86 %) and as the levulinoyl ester, by reaction of 18 with a mixture of levulinic acid, DCC, and DMAP in CH 2 Cl 2 to produce compound 20 (73 %). The benzylidene acetal protecting group of compounds 19 and 20 were removed by heating at 90
• C with 85 % AcOH yielding diols 21 (92 %) and 22 (75 %), respectively. The primary OH-6 groups of the diols 21 and 22 were selectively protected as TBDPS ethers by reaction with TBDPSCl and imidazole in DMF to synthesize the glycosyl acceptors 23 and 24 in 81 % yields, respectively.
The monosaccharide building blocks 11, 12 and 23, 24 contained all needed protecting groups in the correct positions. Synthesis of a series of stereoselective glycosidation reactions was attempted (Scheme 2). Coupling of the donor 11 onto acceptors 23 and 24in CH 2 Cl 2 -Et 2 O (4:1) at -5
• C → 0 • C in the presence of a mixture of TMSOTf-NIS to promote reaction produced the disaccharides 25 and 26 that were isolated in 40 % and 50 % yields, respectively. Under typical conditions, condensation of the fully protected donor 12 onto acceptors 23 and 24 generated the targeted disaccharides 27 and 28 in moderate and equal yield (46 %).
1 H NMR analysis of the crude disaccharides 25-28 revealed, as expected, that the β-stereoisomer was formed in all reactions as a sole reaction product. The stereoselectivity observed is attributed to the participation of the acetyl or levulinoyl neighboring groups on the C-2 positions of the donors 11 and 12, respectively. The coupling constant J 1',2' of the disaccharides 25-28 was 8.2 Hz while the four C'-1 carbons resonated at δ 100.6, 100.5, 100.6 and 100.7 ppm, and the four C-1 carbons appeared at δ 100.4, 100.6, 100.3 and 100.4 ppm, respectively, confirming β-stereochemistry. Changing solvents, by performing the reaction in CH 3 CN, or varying the promoter, by using only a catalytic amount of TMSOTf, or reaction temperature did not improve the yields. To investigate whether the donor/acceptor ratio had any effect on glycosidation, an increased ratio of the donor to acceptor was examined. Again, coupling of 11 and 23 (2.5:1 ratio), under the conditions mentioned previously, produced the disaccharide 25 (40 %) together with some unreacted donor that was recovered by chromatography. Increasing the acceptor/donor ratio was unsuccessful but the excess of the acceptor was recovered quantitatively. The moderate yield of the glycosidation step may have resulted from the bulky 6-O-tert-butyldiphenylsilyl in conjunction with To test the present protecting group strategy for regioselective sulfonation and deprotection steps, the preparation of a sulfated disaccharide fragment was investigated. As shown in Scheme 3, the levulinoyl group of the disaccharide 27 was removed by simple treatment with NaOMe in MeOH for 2 h to produce 29 in 88 % yield. Reduction and concomitant acetylation of the azide 29 using thioacetic acid [25] 13 C-NMR spectrum of compound 31 indicated that C-1, C-2, C-1' and C-2' appeared at 98.7, 46.2, 99.6 and 79.6 ppm, respectively. The expected downfield shift of the 2'-H signal of 31 relative to its non-sulfated precursor 30 were found to be in good agreement with the literature [26] and clearly indicated the sulfation of O-2'. Hydrogenation of the O-sulfated disaccharide 31 with 10 % Pd/C was troublesome and required prolonged reaction time. Reduction of 31 with 10 % Pd/C and H 2 in EtOH solution (4 bar) produced the sub-target disaccharide 33 after 7 days in 29 % yield. Obviously, the yield was very low. Some materials were isolated without the corresponding sulfate ester probably due to the instability of the sulfate group under the reaction conditions. In a trial to alleviate this problem, the PMB group of the O-sulfated disaccharide 31 was selectively cleaved with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in wet CH 2 Cl 2 and the reaction was buffered with di-tert-butyl pyridine to minimize the decomposition of sulfate ester, resulting in the disaccharide 32 in 60 % yield. The O-benzyl groups were removed by 10 % Pd/C and H 2 giving the disaccharide 33 (51 %) after about 72 h of reaction. The primary OH-6' was selectively oxidized with catalytic 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) and sodium hypochloride as co-oxidant [27] . The pH of the solution was carefully monitored below pH = 10 to avoid cleavage of the sulfate group. Finally, the silyl ether (TBDPS group) of OH-6 was successfully cleaved with HF/Py to produce the O-sulfated disaccharide 34 in 47 % overall yield.
In conclusion, we demonstrated a simple method for the assembly of a number of welldefined disaccharides containing all the protecting groups in the required positions. The unique pattern of protecting groups made clear distinction between the positions needed to be sulfated and those remaining as free hydroxyl groups. The important features of the reported approach are: a) Acetyl and/or levulinoyl esters protect temporary the positions to be sulfated, while benzyl ethers are used for permanent protection. b) The anomeric positions are protected as allyl ethers, whereas the 4'-positions are masked as PMB ethers. The orthogonality of the PMB and allyl groups can then be used for further elongation of the chain by recurrent deprotection and activation steps. c) The hydroxyl group OH-6 of glucosamine moieties is protected as TBDPS ether to avoid oxidation. d) The primary OH-6' of the sulfated disaccharide was selectively oxidized to a carboxylic acid using TEMPO / NaOCl mixture. As exemplified by the synthesis of 34, the present pattern of the protecting groups proved to be compatible with the oxidation and sulfonation steps and could be used for the preparation of several O-sulfonated fragments.
Experimental

General methods
All solvents were distilled from the appropriate drying agents prior to use; dichloromethane, toluene, benzene were distilled from P 2 O 5 and stored over molecular sieves (4Å). DMF and CH 3 CN were distilled from CaH 2 and stored over molecular sieves (4Å). Et 2 O, THF and 1,4-dioxane were distilled from LiAlH 4 . Molecular sieves were crushed and activated in vacuo at 390
• C for 4 hours prior to use.TLC analysis was conducted on silica gel plates (EM Science; Kieselgel 60 F254) and the products were detected by UV light after charring with 5 % sulfuric acid in methanol. Column chromatography was performed on silica gel 60 (EM Science, 70-230 mesh). Size exclusion column chromatography was performed on Sephadex LH-20 (methanol/dichloromethane 1:
1 H-13 C correlation) and 13 C-NMR were recorded on Varian 300 MHz and 500 MHz spectrometers equipped with a SUN off-line editing workstation. Matrix-assisted Laser Desorption Ionization-Time-of-Flight (MALDI-TOF) mass spectrometry was performed using a HP MALDI-TOF spectrometer using gentisic acid as the matrix. Optical rotations were measured using a JASCO P-1020 polarimeter and [α] D -values are given in units of deg cm 2 mg −1 .
.49 mmol) dissolved in 6.0 mL of DMF was treated with benzyl bromide (900 µL, 5.58 mmol) and Bu 4 NI (30 mg) at 0 • C. NaH (100 mg) was added incrementally over 30 min. The mixture was allowed to stir 1 h. The reaction mixture was quenched with 2.0 ml H 2 O. The mixture was poured into H 2 O and extracted with CHCl 3 (3 × 20 mL). The organic phase was separated, dried (MgSO 4 ) and evaporated to dryness. Purification of the crude material on silica gel column using EtOAc-hexane 
1,5-anhydro-3-O-benzyl-2-deoxy-D-arabino-hex-1-enitol (4)
To a stirred solution of glucal 3 (610 mg, 1.62 mmol) dissolved in 5 mL of THF at -10 • C was added 2.0 mL (1M solution in THF) of TBAF. The mixture was stirred for 3 h at the same temperature; 10 mL of H 2 O was added and the mixture was extracted with CDCl 3 (3 × 20 mL). The organic layer was dried (MgSO 4 ) and evaporated to dryness. Purification on silica gel using EtOAc-toluene (1:1, R f 0. 19 
Dibutyltin dimethoxide (94 mg, 0.319 mmol) was added to a stirred solution of glucal 4 (70 mg, 0.29 mmol) dissolved in 20 mL of dry toluene. The mixture was refluxed for 1 h, after which the solvent was reduced into half of its volume under vacuum. Benzyl bromide (50 µL, 0.319 mmol) and Bu 4 NI (160 mg, 0.435 mmol) was subsequently added and the mixture was stirred at 50
• C for 16 h. H 2 O (10 mL) was added and the content of the flask was partitioned between EtOAc-H 2 O (cold) 50 mL (1:1 v/v). The organic phase was separated and dried (MgSO 4 ). Pure glucal 5 was obtained in (76 %, 72 mg) after purification of the crude product on silica gel column using toluene-EtOAc mixture (5:1, 
.74 mmol) dissolved in 5 mL of DMF was cooled to 0
• C and treated subsequently with TBDMS chloride (2 g, 13.48 mmol) and imidazole (2 g, 29.37 mmol). The reaction was allowed to stir at constant temperature. After 6 h the solvent was evaporated to dryness under high vacuum (temperature of the bath should not exceed 35
• C). The residue was mixed with 100 mL EtOAc-H 2 O (1:1 v/v). The organic phase was separated, dried (MgSO 4 ) and evaporated. The pure glucal 7 (90 %, 2.3 g) was obtained by silica gel column chromatography purification using hexaneEtOAc (6:1, R f 0.2). The product, recovered as colorless oil, crystallized to a white waxy solid. Spectral data were identical as previously reported [24] 
To a stirred solution of glucal 7 (1 g, 2.67 mmol), p-methoxybenzyl chloride (667 mg, 4.01 mmol), and Bu 4 NI (30 mg) dissolved in 3 mL of DMF, 100 mg of NaH were added over 10 min. in three equal portions at 0
• C. The reaction was allowed to stir for 1h at the same temperature and for 30 min at rt. The reaction mixture was combined with EtOAc-H 2 O (100 mL, 1:1 v/v). The organic phase was separated, washed once with brine, dried (MgSO 4 ), evaporated to dryness and the residue was purified on silica gel column (EtOAc-hexane 1:4, R f 0.23) to produce pure glucal 8 ( 
Glucal 8 (1 g, 2.02 mmol), dissolved in 5 mL of THF at -10
• C, was treated with 2.5 mL (2.50 mmol) of TBAF solution (1M) in THF. The mixture was stirred continuously for 3 h. H 2 O (5 mL) was added and the solution was extracted with CH 2 Cl 2 (3 × 10 mL). The organic extracts was dried and evaporated to dryness. The residue was purified on silica gel column using toluene-EtOAc (2:1, R f 0.20) to furnish 500 mg (93 %) of pure 9.
[α] D 64.8 (c 0.97 CH 2 Cl 2 ). • C. Bu 4 NI (10 mg) was added followed by NaH (30 mg). The reaction was stirred for 30 min at the same temperature after which an additional 30 mg of NaH were added. After stirring continuously for 2 h at rt, the mixture was partitioned between EtOAc-H 2 O (100 mL, 1:1 v/v). The organic phase was separated, dried (MgSO 4 ), and the solvent was evaporated to dryness. Purification on silica gel column using hexane-EtOAc (9:1, R f 0.19) produced pure 6 (100 mg, 73 %).
Method 2 : A solution of glucal 9 (1 g, 3.75 mmol) dissolved in 10 mL of DMF was treated with benzyl bromide (1.76 mL, 11.27 mmol) at 0
• C. Bu 4 NI (10 mg) was added followed by NaH (100 mg). The reaction mixture was stirred for 30 min. An additional 100 mg of NaH were added. Stirring continued for 2 h at rt. The mixture was partitioned between EtOAc-H 2 O (100 mL, 1:1 v/v). The organic phase was separated, dried (MgSO 4 ), and the solvent was evaporated to dryness. Pure 6 (1.3 g, 78 %) was recovered after purification on silica gel column using hexane-EtOAc (9:1, R f 0. 19 1-C), 138.4, 138.0, 130.3, 129.6, 128.4, 128.3, 127.7 The solvent was evaporated in a stream of nitrogen gas. After drying for 1 h under high vacuum, the epoxide was dissolved in 10 mL of CH 2 Cl 2 . EtSH (1.48 mL, 20.0 mmol) was added. The mixture was cooled to -78
• C and trifluoroacetic anhydride (100 µL) was added dropwise. Stirring was continued at -78
• C for 30 min, after which the reaction mixture was allowed to warm to rt. The solvent was removed under a stream of nitrogen gas and the residue was purified on silica gel column using EtOAc-hexane 
Ethyl 2-O-acetyl-3,6-di-O-benzyl-4-O-(4-methoxybenzyl)-1-thio-β-D-glucopyranoside (11)
A solution of thioglycoside 10 (500 mg, 0.95 mmol) dissolved in 5.0 mL of pyridine was treated with 3.0 mL of Ac 2 O and 20 mg of DMAP. Stirring was continued at rt for 2 h after which the solvent was evaporated to dryness. The crude material was purified using silica gel column chromatography. 
Ethyl 3,6-di-O-benzyl-4-O-(4-methoxybenzyl)-2-O-levulinoyl-1-thio-β-D-glucopyranoside (12).
A solution of thioglycoside 10 (892 mg, 1.70 mmol) dissolved in 15 mL of CH 2 Cl 2 at -20 • C was subsequently treated with 300 mg (2.50 mmol) of levulinic acid, 520 mg (4.48 mmol) DCC and 50 mg of DMAP. Stirring was continued at -20
• C for 1 h followed by stirring at rt for additional 12 h. The mixture was diluted with 30 mL of CH 2 Cl 2 , washed with sat. NaHCO 3 , brine, dried (MgSO 4 ) and the solvent was evaporated to dryness. The crude material was purified using silica gel column with hexane-EtOAc (4:1, R f 0.2) yielding pure 12 (900 mg, 85 %) as a colorless oil that crystallized as a white solid. 
Allyl 2-N -acetyl-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranoside (14)
To a stirred solution of 1,3,4,6-tetra-O-acetyl-2-acetamido-2-deoxy-α-D-glucopyranoside (13) (6.2 g, 16.35 mmol) in CH 2 Cl 2 (100 mL), TMSOTf (4.2 mL, 23.2 mmol) was added dropwise. After the mixture was heated at 60
• C for 20 h, it was allowed to cool to rt. Activated powdered molecular sieves (4Å, 5 g) were added and the solution was stirred for 2 h at rt After addition of 6.0 mL of allyl alcohol, the mixture was stirred at rt for 20 h. The reaction mixture was quenched with Et 3 N (1.0 mL). The mixture was filtered over Celite (5 g) and washed thoroughly with 10 % MeOH-CH 2 Cl 2 . The combined filtrate and washings were evaporated to dryness. Purification on silica gel column using 5 % MeOH-CH 2 Cl 2 (R f 0.25) produced pure 14 (6.7 g, 91 %). Crude 15 was dissolved in 80 mL CH 3 CN and 5.35 g (35.24 mmol) of benzylidene dimethylacetal was added. The reaction mixture was acidified by camphor sulfonic acid to pH = 3 and it was stirred overnight (18 h) at rt. The solvent was removed under high vacuum and the crude product was purified using silica gel column using CH 2 Cl 2 -MeOH (95:5, R f 0.4, to furnish (4.1 g, 77 %) of pure 16 as a white solid. • C. The mixture was cooled to r.t. H 2 SO 4 (1N) was added dropwise until no additional precipitation of BaSO 4 (pH = 3) was observed. The white precipitate was filtered after centrifugation. The filtrate was evaporated under high vacuum to give crude 17 as a white solid (2 g, 91 %) that was used in the next procedure without further purification.
Crude 17 was dissolved in 10 mL of H 2 O/MeOH (5:1 v/v) and treated with 400 mg of K 2 CO 3 , 3 mg of CuSO 4 .5H 2 O and Tf 3 N solution. The Tf 3 N solution was prepared by reaction of 1 g of NaN 3 and 1 g of Tf 2 O in 5 mL of CH 2 Cl 2 MeOH (6 mL) was added to ensure formation of a homogenous mixture. The mixture was allowed to stir at rt for 16 h. The mixture was filtered and the filtrate was evaporated under vacuum. The crude product was purified on silica gel column using CH 2 Cl 2 -MeOH (20:1, R f 0.5) to yield pure 18 (1.6 g, 74 %). • C. NaH (100 mg, 4.11 mmol) was added incrementally (25 mg every 10 min.) The reaction mixture was allowed to stir for 1 h at rt, The reaction was quenched by pouring into a mixture of 200 g ice / 200 mL EtOAc. The phases were separated, and the organic phase was washed once with water and evaporated until dryness. The crude material was purified using silica gel column (CH 2 Cl 2 , R f = 0.63) to yield pure 19 (1.1 g, 86 %) as a waxy white solid. 3 g, 6 .25 mmol) and DMAP (35 mg) were subsequently added. The mixture was stirred for 1h at -20
• C followed by stirring overnight at r.t. The mixture was diluted with CH 2 Cl 2 (40 mL), washed with NaHCO 3 , brine, dried (MgSO 4 ) and evaporated under vacuum. Purification using silica gel column (CH 2 4 Hz, J 2,3 9.7 Hz, 1H, 2-H), 2.90-2.83, 2.82-2.77 (2m, 2H, CH 2 CH 2 CO), 2.70-2.60, 2.60-2.53 (2m, 2H,OCOCH 2 ), 2.14 (s, 3H, COCH 3 ). • C for 15 h after which the solvent and volatiles were removed under vacuum. The residue was purified using column chromatography with 5 % CH 2 Cl 2 -MeOH (R f 0.3) to yield 21 (800 mg, 92 %) as a clear heavy oil. , J 2,3 10.3, J 2,1 7.8 Hz, 1H, H-2), 3.06 (s br, 1H, OH) , 2.97-2.83, 2.82-2.77 (2m, 2H, CH 2 CH 2 CO), 2.70-2.60, 2.60-2.50 (2m, 2H,OCOCH 2 ), 2.19 (s, 3H, COCH 3 ). 
Thioglycoside 11 (300 mg, 0.53 mmol) and the acceptor 23 (233 mg, 0.40 mmol) were coevaporated twice with 10 mL of toluene and dried under vacuum for 3 h. The mixture was dissolved in 4 mL of CH 2 Cl 2 containing 0.5 ml Et 2 O and stirred with 300 mg of molecular sieves (4Å) for 1 h at rt. The mixture was cooled to -5
• C. N-iodosuccinimide (113 mg, 0.5 mmol) and 8 µL of TMSOTf were subsequently added. The mixture was stirred for 15 min. and thin layer chromatography demonstrated the consumption of the donor. The reaction mixture was quenched with pyridine. The insoluble residue and molecular sieves were removed by filtration, washed thoroughly with 10 % MeOH-CH 2 Cl 2 (30 ml), and the combined filtrate and the washing were evaporated to dryness. The residue was purified on silica gel column using 5 % toluene-EtOAc (R f 0.23) to produce pure 25 (230 mg, 40 %) as a colorless oil. ), 113.8, 100.6 (C-1'), 100.5 (C-1), 83.4 (C-2'), 81.9 (C-3), 80.9 (C-3'), 79.5 (C-4), 75.5 (CH 2 -Ph), 74.7 (CH 2 -Ph), 73.6 (CH 2 -Ph), 73.5 (C-5'), 71.8 (C-5), 70.7 (C-4'), 69.9 (C-6), 68.9 (CH 2 -CH=CH 2 ), 64.4 (C-6'), 62.7 (C-2), 55. 
The reaction between thioglycoside 12 (311 mg, 0.5 mmol) and the acceptor 23 (268 mg, 0.46 mmol) was conducted as described previously for compound 25. The residue was purified on silica gel column using 5 % toluene-EtOAc (R f 0.26) to generate pure 27 (244 mg, 46 %) as a colorless oil. C-1') , 100.4 (C-1), 83.5 (C-2'), 76.1 (CH2-Ph), 75.5 (C-3), 74.1 (CH 2 -Ph), 73.7 (CH 2 -Ph), 72.8 (C-4), 72.3 (6'-C), 70.1 (C-5), 69.9 (C-5'), 68.7 (CH 2 -CH=CH 2 ), 67.6 (C-3'), 64.3 (C-4') 
A solution of the disaccharide 27 (50 mg, 0.043 mmol), dissolved in MeOH (3 mL), was treated with NaOCH 3 (1 mL, 1M in MeOH) and allowed to stir for 3 h. The mixture was neutralized by addition of H + -type resin. The resin was recovered by filtration, washed thoroughly with MeOH, and the solvent was removed under vacuum. The residue was purified on silica gel column using 5 % toluene-EtOAc (R f 0.25) to produce 29 (40 mg, 88 %) as a clear thick oil. To a solution of 32 (29 mg, 0.028 mmol) dissolved in EtOH (15 mL), Pd(OAc) 2 (100 mg) was added and the mixture was stirred at rt under a H 2 atmosphere for 72 h. The reaction was monitored by TLC. After 48 h, the solution was filtered and Pd(OAc) 2 (100 mg) was added a second time. The filtrate was concentrated under reduced pressure to yield 33 as a colorless glass. The crude product was used as such for the subsequent procedure without further purification. • C and the pH adjusted to 8.5 by dropwise addition of aqueous NaOH (1 M) solution. NaOCl solution, adjusted to pH 8.5 prior to use, was added dropwise (about 100 µL were consumed) and the progress of the reaction was carefully monitored by TLC. The reaction was determined to be complete after 30 min. The mixture was purified by passing it through a column containing Sephadex LH-20 using 0-90 % MeOH in H 2 O to generate pure (n-Propyl)-6-O-(tertbutyldiphenylsilyl)-2-deoxy-2-acetamido-4-O-(2'-O-sulfo-β − Dglucuronic acid)-β − D-glucopyranoside disodium salt (9 mg, 51 %) as a white solid. MS: M + 802 calculated for C 33 H 45 O 15 NSSiNa 2 . Found: 827, M + + Na. A solution of the oxidation product (6 mg, 0.007 mmol) in pyridine (300 µL) was carefully treated with a solution of 70 % HF-Pyridine (10 µL) at -5
• C. The mixture was stirred for 1h at the same temperature, followed by stirring overnight at rt. The solvent and volatiles were evacuated under reduced pressure and the remaining residue was passed through a column containing Sephadex LH-20 using 0-20 % MeOH in H 2 O to produce pure 34 (1.9 mg, 47.5 %) as a white solid. 
